AUS
NZ
UK
CA
USA
IND
_06_19_2026_12_34_15_139937.jpg)
Spirax Group PLC (LSE:SPX), based in Cheltenham, England, has reported mixed financial results for the first half of the year. Despite a rise in pretax profit of 9.5% to £124.8 million from £114.0 million in the previous year, revenue experienced a decline. Revenue fell 2.8% to £827.0 million, down from £850.8 million. Operating costs also decreased by 5.4% to £679.8 million, compared to £718.6 million the previous year. Despite these fluctuations, the company raised its interim dividend by 3.3% to 47.5 pence per share, up from 46.0 pence.
Debt Reduction and Financial Position
Spirax Group's net debt decreased by 4.0%, standing at £718.3 million compared to £748.3 million at the end of the previous period. This reduction in debt highlights the company's efforts to manage its financial position effectively amidst the current economic climate.
Challenges and Operational Adjustments
Chief Executive Officer Nimesh Patel commented on the results, noting that the company faced challenges due to a weak macroeconomic environment in key markets and adverse currency effects. The first-half results were slightly below expectations, prompting the company to accelerate operational improvements and strategically focus investments on global trends and high-growth markets to drive long-term growth.
Segment Performance and Market Conditions
Performance varied across different segments. Revenue from Steam Thermal Solutions fell by 6.3% to £430.8 million, while Electric Thermal Solutions saw a 2.7% increase, reaching £197.7 million. Revenue from Watson-Marlow fluid solutions remained unchanged at £198.5 million. The company observed weaker industrial production in key regions including Germany, France, and the US, which collectively accounted for 40% of Spirax's sales last year.
Outlook and Future Expectations
Looking ahead, Spirax Group remains cautious about the scale of anticipated improvements in industrial production for the second half of the year. The company has adopted a conservative approach in its planning and expectations. For the full year, Spirax expects to achieve mid-single-digit organic revenue growth and maintain an adjusted operating profit margin comparable to the 21% reported in 2023.
